To confirm nucleolin as a viable target for selective delivery, nucleolin expression was compared between MIA PaCa-2 pancreatic cancer cells and non-malignant L929 fibroblasts (Figure S3). The gene discussed is NUCLEOLIN; the disease is familial pancreatic carcinoma.